Dengue Virus - 05/08/11
Résumé |
Dengue is the most prevalent arthropod-borne virus affecting humans today. The virus group consists of 4 serotypes that manifest with similar symptoms. Dengue causes a spectrum of disease, ranging from a mild febrile illness to a life-threatening dengue hemorrhagic fever. Breeding sites for the mosquitoes that transmit dengue virus have proliferated, partly because of population growth and uncontrolled urbanization in tropical and subtropical countries. Successful vector control programs have also been eliminated, often because of lack of governmental funding. Dengue viruses have evolved rapidly as they have spread worldwide, and genotypes associated with increased virulence have spread across Asia and the Americas. This article describes the virology, epidemiology, clinical manifestations and outcomes, and treatments/vaccines associated with dengue infection.
Le texte complet de cet article est disponible en PDF.Keywords : Dengue virus, Flavivirus, Infection, Clinical diagnosis, Vaccines
Plan
| Funding Support: TMR is supported by research awards, W81XWH-BAA-06-1 and W81XWH-BAA-06-2, from the United States Department of Defense. |
Vol 30 - N° 1
P. 149-160 - mars 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

